Cargando…
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel
Peripheral neuropathy (PN) is a dose-limiting, painful adverse reaction associated with the use of paclitaxel. This common side effect was often partially attributed to the solvent used for solubilization of the highly hydrophobic drug substance. Therefore, the development of alternative formulation...
Autores principales: | Huang, Jhih-Wei, Kuo, Ching-Hua, Kuo, Han-Chun, Shih, Jin-Yuan, Tsai, Teng-Wen, Chang, Lin-Chau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978375/ https://www.ncbi.nlm.nih.gov/pubmed/33740022 http://dx.doi.org/10.1371/journal.pone.0248942 |
Ejemplares similares
-
Differences in Fatty Acid Oxidation between Nab-Paclitaxel-
and Solvent-Based Paclitaxel-Treated A549
Cells Based on Metabolomics
por: Huang, Jhih-Wei, et al.
Publicado: (2021) -
Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel
por: Chen, Nianhang, et al.
Publicado: (2014) -
Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel()
por: de Leon, Maria C.B., et al.
Publicado: (2013) -
nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017) -
Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
por: Kokubu, Hiraku, et al.
Publicado: (2023)